1 01/12/2022 30/11/2023 2023-11-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2022-12-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13045264 2022-12-01 2023-11-30 13045264 2023-11-30 13045264 2022-11-30 13045264 2021-12-01 2022-11-30 13045264 2022-11-30 13045264 2021-11-30 13045264 bus:RegisteredOffice 2022-12-01 2023-11-30 13045264 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 13045264 bus:Director1 2022-12-01 2023-11-30 13045264 core:WithinOneYear 2023-11-30 13045264 core:WithinOneYear 2022-11-30 13045264 bus:Micro-entities 2022-12-01 2023-11-30 13045264 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 13045264 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 13045264 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 13045264 bus:FullAccounts 2022-12-01 2023-11-30
Company registration number: 13045264
Iguanamed Limited
Unaudited filleted financial statements
30 November 2023
Iguanamed Limited
Contents
Directors and other information
Director's report
Accountants report
Statement of financial position and notes to the financial statements
Iguanamed Limited
Directors and other information
Director Mr David Bentley
Company number 13045264
Registered office 32 The Wynd
Wynyard
Billingham
TS22 5QE
Accountants Censis
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
Iguanamed Limited
Director's report
Year ended 30 November 2023
The director presents his report and the unaudited financial statements of the company for the year ended 30 November 2023.
Director
The director who served the company during the year was as follows:
Mr David Bentley
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 12 August 2024 and signed on behalf of the board by:
Mr David Bentley
Director
Iguanamed Limited
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of Iguanamed Limited
Year ended 30 November 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Iguanamed Limited for the year ended 30 November 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of Iguanamed Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Iguanamed Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Iguanamed Limited and its director as a body for our work or for this report.
It is your duty to ensure that Iguanamed Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Iguanamed Limited. You consider that Iguanamed Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Iguanamed Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Censis
Chartered Accountants
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
12 August 2024
Iguanamed Limited
Statement of financial position
30 November 2023
2023 2022
£ £
Current assets 5,613 3,065
Creditors: amounts falling due within one year ( 4,807) ( 2,129)
_______ _______
Net current assets 806 936
_______ _______
Total assets less current liabilities 806 936
Accruals and deferred income ( 720) ( 720)
_______ _______
Net assets 86 216
_______ _______
Capital and reserves 86 216
_______ _______
Notes to the financial statements
Iguanamed Limited
Year ended 30 November 2023
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2022: 1 ).
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 12 August 2024 , and are signed on behalf of the board by:
Mr David Bentley
Director
Company registration number: 13045264
The company is a private company limited by shares, registered in England and Wales.